The Alzheimer's associated 5' region of the SORL1 gene cis regulates SORL1 transcripts expression

Neurobiology of Aging

Volumn 33, Issue 7, 2012, Pages 1485.e1-1485.e8

  McCarthy, Jeanette J ^a   Saith, Sunita ^a   Linnertz, Colton ^a   Burke, James R ^b,c   Hulette, Christine M ^c   Welsh Bohmer, Kathleen A ^c   Chiba Falek, Ornit ^a,b,c  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Correlation to gene expression; MRNA; SORL1; Splicing

Indexed keywords

MESSENGER RNA;

ADULT; ALLELE; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; EXON SKIPPING; FEMALE; FRONTAL CORTEX; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MALE; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SORL1 GENE; TEMPORAL CORTEX; TRANSCRIPTION REGULATION;

EID: 84861199038     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.10.004     Document Type: Article

References (31)

1. Andersen O.M., Reiche J., Schmidt V., Gotthardt M., Spoelgen R., Behlke J., von Arnim C.A., Breiderhoff T., Jansen P., Wu X., Bales K.R., Cappai R., Masters C.L., Gliemann J., Mufson E.J., Hyman B.T., Paul S.M., Nykjaer A., Willnow T.E. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13461-13466.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Bengtsson M., Stahlberg A., Rorsman P., Kubista M. Gene expression profiling in single cells from the pancreatic islets of langerhans reveals lognormal distribution of mRNA levels. Genome Res 2005, 15:1388-1392.
4. Bettens K., Brouwers N., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Sleegers K. SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Hum. Mutat 2008, 29:769-770.
5. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
6. Cellini E., Tedde A., Bagnoli S., Pradella S., Piacentini S., Sorbi S., Nacmias B. Implication of sex and SORL1 variants in Italian patients with Alzheimer disease. Arch. Neurol 2009, 66:1260-1266.
7. Chiba-Falek O., Nichols M., Suchindran S., Guyton J., Ginsburg G.S., Barrett-Connor E., McCarthy J.J. Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study. BMC Med. Genet 2010, 11:9.
8. Cuenco K.T., Green R.C., Zhang J., Lunetta K., Erlich P.M., Cupples L.A., Farrer L.A., DeCarli C. Magnetic resonance imaging traits in siblings discordant for Alzheimer disease. J. Neuroimaging 2008, 18:268-275.
9. Dodson S.E., Gearing M., Lippa C.F., Montine T.J., Levey A.I., Lah J.J. LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J. Neuropathol. Exp. Neurol 2006, 65:866-872.
10. Emilsson V., Thorleifsson G., Zhang B., Leonardson A.S., Zink F., Zhu J., Carlson S., Helgason A., Walters G.B., Gunnarsdottir S., Mouy M., Steinthorsdottir V., Eiriksdottir G.H., Bjornsdottir G., Reynisdottir I., Gudbjartsson D., Helgadottir A., Jonasdottir A., Jonasdottir A., Styrkarsdottir U., Gretarsdottir S., Magnusson K.P., Stefansson H., Fossdal R., Kristjansson K., Gislason H.G., Stefansson T., Leifsson B.G., Thorsteinsdottir U., Lamb J.R., Gulcher J.R., Reitman M.L., Kong A., Schadt E.E., Stefansson K. Genetics of gene expression and its effect on disease. Nature 2008, 452:423-428.
11. Grear K.E., Ling I.F., Simpson J.F., Furman J.L., Simmons C.R., Peterson S.L., Schmitt F.A., Markesbery W.R., Liu Q., Crook J.E., Younkin S.G., Bu G., Estus S. Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimer's disease brain. Mol. Neurodegener 2009, 4:46.
12. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
13. Heinzen E.L., Ge D., Cronin K.D., Maia J.M., Shianna K.V., Gabriel W.N., Welsh-Bohmer K.A., Hulette C.M., Denny T.N., Goldstein D.B. Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol 2008, 6:e1.
14. Hubbard T., Andrews D., Caccamo M., Cameron G., Chen Y., Clamp M., Clarke L., Coates G., Cox T., Cunningham F., Curwen V., Cutts T., Down T., Durbin R., Fernandez-Suarez X.M., Gilbert J., Hammond M., Herrero J., Hotz H., Howe K., Iyer V., Jekosch K., Kahari A., Kasprzyk A., Keefe D., Keenan S., Kokocinsci F., London D., Longden I., McVicker G., Melsopp C., Meidl P., Potter S., Proctor F., Rae M., Rios D., Schuster M., Searle S., Severin J., Slater G., Smedley D., Smith J., Spooner W., Stabenau A., Stalker J., Storey R., Trevanion S., Ureta-Vidal A., Vogel J., White S., Woodwark C., Birney E. Ensembl 2005 Nucl. Acids Res 2005, 33(suppl 1):D447-D453.
15. Jacobsen L., Madsen P., Moestrup S.K., Lund A.H., Tommerup N., Nykjaer A., Sottrup-Jensen L., Gliemann J., Petersen C.M. Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein. J. Biol. Chem 1996, 271:31379-31383.
16. Lee J.H., Cheng R., Honig L.S., Vonsattel J.P., Clark L., Mayeux R. Association between genetic variants in SORL1 and autopsy-confirmed Alzheimer disease. Neurology 2008, 70:887-889.
17. Lee J.H., Cheng R., Schupf N., Manly J., Lantigua R., Stern Y., Rogaeva E., Wakutani Y., Farrer L., St George-Hyslop P., Mayeux R. The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch. Neurol 2007, 64:501-506.
18. Li Y., Rowland C., Catanese J., Morris J., Lovestone S., O'Donovan M.C., Goate A., Owen M., Williams J., Grupe A. SORL1 variants and risk of late-onset Alzheimer's disease. Neurobiol. Dis 2008, 29:293-296.
19. Liang W.S., Dunckley T., Beach T.G., Grover A., Mastroeni D., Ramsey K., Caselli R.J., Kukull W.A., McKeel D., Morris J.C., Hulette C.M., Schmechel D., Reiman E.M., Rogers J., Stephan D.A. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol. Genomics 2008, 33:240-256.
20. Linnertz C., Saucier L., Ge D., Cronin K.D., Burke J.R., Browndyke J.N., Hulette C.M., Welsh-Bohmer K.A., Chiba-Falek O. Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues. PLoS One 2009, 4:e7480.
21. Liu F., Arias-Vasquez A., Sleegers K., Aulchenko Y.S., Kayser M., Sanchez-Juan P., Feng B.J., Bertoli-Avella A.M., van Swieten J., Axenovich T.I., Heutink P., van Broeckhoven C., Oostra B.A., van Duijn C.M. A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am. J. Hum. Genet 2007, 81:17-31.
22. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
23. Meng Y., Lee J.H., Cheng R., St.George-Hyslop P., Mayeux R., Farrer L.A. Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport 2007, 18:1761-1764.
24. Myers A.J., Gibbs J.R., Webster J.A., Rohrer K., Zhao A., Marlowe L., Kaleem M., Leung D., Bryden L., Nath P., Zismann V.L., Joshipura K., Huentelman M.J., Hu-Lince D., Coon K.D., Craig D.W., Pearson J.V., Holmans P., Heward C.B., Reiman E.M., Stephan D., Hardy J. A survey of genetic human cortical gene expression. Nat. Genet 2007, 39:1494-1499.
25. Offe K., Dodson S.E., Shoemaker J.T., Fritz J.J., Gearing M., Levey A.I., Lah J.J. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J. Neurosci 2006, 26:1596-1603.
26. Rogaeva E., Meng Y., Lee J.H., Gu Y., Kawarai T., Zou F., Katayama T., Baldwin C.T., Cheng R., Hasegawa H., Chen F., Shibata N., Lunetta K.L., Pardossi-Piquard R., Bohm C., Wakutani Y., Cupples L.A., Cuenco K.T., Green R.C., Pinessi L., Rainero I., Sorbi S., Bruni A., Duara R., Friedland R.P., Inzelberg R., Hampe W., Bujo H., Song Y.Q., Andersen O.M., Willnow T.E., Graff-Radford N., Petersen R.C., Dickson D., Der S.D., Fraser P.E., Schmitt-Ulms G., Younkin S., Mayeux R., Farrer L.A., St George-Hyslop P. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet 2007, 39:168-177.
27. Scherzer C.R., Offe K., Gearing M., Rees H.D., Fang G., Heilman C.J., Schaller C., Bujo H., Levey A.I., Lah J.J. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch. Neurol 2004, 61:1200-1205.
28. Schmidt V., Sporbert A., Rohe M., Reimer T., Rehm A., Andersen O.M., Willnow T.E. SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1. J. Biol. Chem 2007, 282:32956-32964.
29. Tan E.K., Lee J., Chen C.P., Teo Y.Y., Zhao Y., Lee W.L. SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese. Neurobiol. Aging 2009, 30:1048-1051.
30. Webster J.A., Myers A.J., Pearson J.V., Craig D.W., Hu-Lince D., Coon K.D., Zismann V.L., Beach T., Leung D., Bryden L., Halperin R.F., Marlowe L., Kaleem M., Huentelman M.J., Joshipura K., Walker D., Heward C.B., Ravid R., Rogers J., Papassotiropoulos A., Hardy J., Reiman E.M., Stephan D.A. Sorl1 as an Alzheimer's disease predisposition gene?. Neurodegener. Dis. 2008, 5:60-64.
31. Yamazaki H., Bujo H., Kusunoki J., Seimiya K., Kanaki T., Morisaki N., Schneider W.J., Saito Y. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J. Biol. Chem 1996, 271:24761-24768.